Immunovative Therapies Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 51
Employees
  • Latest Deal Type
  • Corporate
  • Latest Deal Amount
  • $10M
Latest Deal Amount
  • Investors
  • 2

Immunovative Therapies General Information

Description

Developer of drug products designed to harness the power of the immune system to treat cancer and infectious diseases. The company's drug products incorporate living immune cells as active ingredients for treating cancer, enabling physicians to reduce healthcare costs of patients and improve quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Malcha Technology Park
  • 1 Agudat Sport Hapoel Street
  • Jerusalem 96951
  • Israel
+972 00-000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunovative Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Corporate 18-Dec-2011 $10M 000.00 Completed Generating Revenue
6. Early Stage VC 00.00 00.00 Completed Startup
5. Early Stage VC 07-Jan-2008 00.00 000 Completed Startup
4. Grant 01-Jan-2008 00000 00000 Completed Startup
3. Early Stage VC 01-May-2006 00000 00000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Early Stage VC 01-May-2004 Completed Startup
To view Immunovative Therapies’s complete valuation and funding history, request access »

Immunovative Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of drug products designed to harness the power of the immune system to treat cancer and infectious diseases. T
Biotechnology
Jerusalem, Israel
51 As of 2016
000.00
000000000000 000.00

00000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000000000000
Mont-Saint-Guibert, Belgium
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000 0

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000 000000000
New York, NY
0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunovative Therapies Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Promethera Biosciences Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
000000 00000000000 Venture Capital-Backed New York, NY 0000 00000000000 0000
000000000 Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000000 0000 Formerly VC-backed Jerusalem, Israel 00 00000 00000000 00000
000000000 Formerly VC-backed Culver City, CA 000 00000 00000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Immunovative Therapies Executive Team (6)

Name Title Board Seat Contact Info
Michael Har-Noy Founder, Chief Executive Officer & Chief Science Officer
Dganit Cohen Director, Human Resources
You’re viewing 2 of 6 executive team members. Get the full list »

Immunovative Therapies Board Members (1)

Name Representing Role Since
Michael Berger Self Board Member 000 0000
To view Immunovative Therapies’s complete board members history, request access »

Immunovative Therapies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunovative Therapies Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Novo Energy Corporation Minority 000 0000 000000 0
The Trendlines Group Accelerator/Incubator Minority 000 0000 000000 0
To view Immunovative Therapies’s complete investors history, request access »